Showing results (441-450 of 644) with videos related to

Sort By:
Pageof 65
Infection Control and Hospital Epidemiology|December 29, 2020
Antimicrobial never events: Objective application of a framework to assess vancomycin appropriatenessJiajun Liu, Nicholas J Mercuro, Susan L Davis, et al.
American Journal of Infection Control|December 2, 2015
Risk factors and acute in-hospital costs for infected pressure ulcers among gunshot-spinal cord injury victims in southeastern MichiganTeena Chopra, Dror Marchaim, Reda A Awali, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2014
Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniaeDavid van Duin, Eric Cober, Sandra S Richter, et al.
Infection Control and Hospital Epidemiology|December 30, 2016
Which Comorbid Conditions Should We Be Analyzing as Risk Factors for Healthcare-Associated Infections?Anthony D Harris, Lisa Pineles, Deverick Anderson, et al.
Journal of Neurotrauma|September 29, 2012
Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-AIshita Siddiq, Eugene Park, Elaine Liu, et al.
The Journal of Antimicrobial Chemotherapy|August 4, 2025
Effectiveness of piperacillin/tazobactam loading dose for extended infusion dosing among patients with Gram-negative bacteraemiaSavan Patel, Sana Mohayya, Arsheena Yassin, et al.
JMIR Mhealth and Uhealth|December 16, 2020
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
British Journal of Cancer|November 21, 1998
A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusionL Paz-Ares, R Kunka, D DeMaria, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health systemTara Reddy, Teena Chopra, Dror Marchaim, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2019
The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identificationOryan Henig, Christopher C Cooper, Keith S Kaye, et al.
Pageof 65